Schizophrenia (SZ) is a serious mental disorder that is typically treated with antipsychotic
medication. Treatment-resistant schizophrenia (TRS) is the condition where symptoms …

Abstract Treatment‑resistant schizophrenia (TRS) is a common phenotype of schizophrenia
that places a considerable burden on patients as well as on society. TRS is known for its …

Schizophrenia (SCZ) is a severe psychiatric disorder with unclear pathophysiology.
Moreover, there is no specific biological marker to help clinicians to define a diagnosis, and …

Schizophrenia (SCZ) is a polygenic, complex mental disorder of which a diagnosis is often
made based on psychiatric history and clinical observation with few available objectives and …

Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …

Since brain tissue is not readily accessible, a new focus in search of biomarkers for
schizophrenia is blood-based expression profiling of non-protein coding genes such as …

Schizophrenia (SZ) is a debilitating psychotic disorder of unknown etiology, and the
diagnosis is essentially based on clinical symptoms. So it is urgent to find an objective and …

With the ongoing evolution in genetics, recent evidence highlights the role of circulatory
microRNA (miRNA) for schizophrenia. The objective of this article is to explore the role of …

Micro RNA (miRNA) research has great implications in uncovering the aetiology of
neuropsychiatric conditions due to the role of miRNA in brain development and function …

Schizophrenia (SZ) is a disease that causes mental disability and affects 1% of the total
population in the world. Our aim was to identify new molecular targets that would help to …